median of one vessel treated per patient and a mean preoperative pedal runoff score of 12 that improved to a mean of 6 after intervention (<7 is considered good pedal runoff); 34% of interventions were a direct revascularization of the intended angiosome. Overall major adverse cardiovascular event rate was <1% at 90 days after the procedure. The majority of patients underwent some form of planned forefoot amputations (single digit, multiple digits, ray amputation, or transmetatarsal amputation). Wound healing at 3 months was 76%. Those who failed to heal underwent below-knee amputations. The clinical efficacy was 25% 6 7% (mean 6 standard error of the mean) at 5 years. The 5-year amputation-free survival rate was 33% 6 8%, and the 5-year major adverse limb event rate was 27% 6 9%. On Cox proportional multivariate analysis, predictors for amputation-free survival were absence of significant coronary disease, a pedal runoff <7, WIfI stage 3 disease, and absence of end-stage renal disease. Predictors for wound healing were improved pedal runoff score (<7), absence of infection, direct angiosome revascularization, and absence of end-stage renal disease.
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). Patients were monitored for late events. Late aortic events were defined as native aortic disease leading to death or further intervention. Planned secondary procedures were excluded. Graft complications included anastomotic aneurysm, graft infection, and branch occlusion. Variables were assessed for association with end points using log-rank methods and Cox proportional hazards regression. Time-to-event analysis was performed using Kaplan-Meier methods.
Results: In-hospital mortality occurred in 40 patients (8%), leaving 476 for surveillance. Age was 69.8 6 10.5 years. Mean follow-up was 4.9 6 4.6 years. (3% of cohort) ; aortic, n ¼ 7; visceral patch, n ¼ 6; side graft, n ¼ 1]; graft infection [n ¼ 12]; renovisceral occlusion/repair [n ¼ 9 (1.9%); side arm graft, n ¼ 8; native, n ¼ 1]; anastomotic stricture, n ¼ 1]) occurring at 4.7 6 4.5 years. Variables predictive of graft-related complication were type II extent (HR, 3.4; P ¼ .002) and distal aortic perfusion/motor evoked potential monitoring (HR, 3.6; P ¼ .02). Freedom from aortic or graft-related event was 80% at 5 years. Freedom from any aortic or graft reintervention was 84% at 5 years. Aorta-related mortality in follow-up was 2.7% and estimated to be 3.1% at 5 years. Overall survival was 67% and 44% at 5 and 10 years, respectively.
Conclusions: After type I to type III TAAA repair, late aortic and graftrelated events are infrequent. Native aortic disease sequelae are more common than graft complication. Aortic events are predicted by complex operation and degree of remaining aorta. Extensive reconstruction drives graft-related events. Ultimately, need for reintervention is rare, and aorta-related mortality is low. These findings verify durability of extensive TAAA repair and serve as benchmarks for endovascular repair.
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In Objective: Transcarotid artery revascularization (TCAR) offers a less invasive option to carotid endarterectomy (CEA) in high-risk patients and has the lowest reported overall stroke rate for any prospective trial of carotid artery stenting. This study compares initial in-hospital outcomes of CEA and TCAR using the Society for Vascular Surgery (SVS) Vascular Quality Initiative TCAR Surveillance Project done in collaboration with the Centers for Medicare and Medicaid Services to create more information for future coverage decisions.
Methods: The SVS TCAR Surveillance Project is designed to evaluate the safety and efficacy of TCAR in real-world practice, using a contemporary
Fig.
Odds ratio of in-hospital stroke/death using different matching methods. CEA, Carotid endarterectomy; CEM, coarsened exact matching; CI, confidence interval; OR, odds ratio; TCAR, transcarotid artery revascularization; TIA, transient ischemic attack.
